Thus, the transcriptional enhancing function of enhancer clusters can be blocked using inhibitors of BRD4 [18], which have been extensively used to study and address the role of these long, accessible, and highly acetylated regulatory regions in the transcriptional regulation of genes of tumor progression or resistance to cancer therapies [18,19,20,21,22]. This evidence concerns the gene BRD4 and cancer.